DUNAD
"DUNAD" is a word mark owned by Dunad Therapeutics Ltd, filed at the USPTO on June 26, 2020. It is registered and covers classes 5 and 42.
- Status
- Registered
- Since November 2, 2021
- Filed
- June 26, 2020
- Registered
- November 2, 2021
- Expires
- Not recorded
- Application no.
- 90022032
- Registration no.
- 6542240
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns DUNAD
The owner and representative on file with the office.
Owner
Dunad Therapeutics Ltd
Cambridge, United Kingdom
Representative
Kimberly Gambrel
Dinsmore & Shohl LLP
What the mark covers
The products and services DUNAD is filed for, grouped by Nice class.
pharmaceutical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Medical preparations for pain, cancer, autoimmune disease, inflammatory disease, neurological disease, psychiatric disease, cardiovascular disease, metabolic disease, endocrine disease, musculoskeletal disease, genetic disease, gastrointestinal disease, haematological disease, respiratory disease, infectious disease, ophthalmological disease, renal disease, hepatic disease, urological disease, gynaecological disease, dermatological disease; Veterinary preparations for cats, dogs, pets, livestock
scientific research in the pharmaceutical field; pharmaceutical research and development services; providing scientific research information in the field of pharmaceutical research and development
What has happened so far
Steps recorded by the USPTO, newest first.
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
- Non-final action e-mailed
10 earlier steps on the official record.
About DUNAD
Who owns the trademark "DUNAD"?
The USPTO trademark "DUNAD" (application 90022032) is owned by Dunad Therapeutics Ltd.
What is the status of "DUNAD"?
Its status at the USPTO is: registered.
When was "DUNAD" registered?
It was registered on November 2, 2021.
Get this data via the API
Everything on this page comes from the Signa API. Pull DUNAD and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2be2-76a1-771b-bfbc-e5a1e332b72b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2be2-76a1-771b-bfbc-e5a1e332b72b",
"object": "trademark",
"mark_text": "DUNAD",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "90022032",
"filing_date": "2020-06-26",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "DUNAD THERAPEUTICS LTD",
"entity_id": null
}
]
}